Aetna Inc. (NYSE:AET) Stake Raised by UMB Bank N A MO
UMB Bank N A MO raised its stake in Aetna Inc. (NYSE:AET) by 1.0% during the second quarter, Holdings Channel reports. The fund owned 7,601 shares of the company’s stock after buying an additional 74 shares during the period. UMB Bank N A MO’s holdings in Aetna were worth $1,154,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also modified their holdings of the company. BlackRock Inc. raised its position in shares of Aetna by 3,374.9% in the first quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock valued at $3,917,344,000 after buying an additional 29,828,390 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Aetna by 3.8% in the first quarter. Vanguard Group Inc. now owns 23,117,526 shares of the company’s stock valued at $2,948,640,000 after buying an additional 838,578 shares during the last quarter. FMR LLC raised its position in shares of Aetna by 2.2% in the first quarter. FMR LLC now owns 7,903,233 shares of the company’s stock valued at $1,008,059,000 after buying an additional 167,261 shares during the last quarter. Bank of New York Mellon Corp raised its position in shares of Aetna by 3.9% in the first quarter. Bank of New York Mellon Corp now owns 4,378,982 shares of the company’s stock valued at $558,540,000 after buying an additional 165,278 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in shares of Aetna by 0.6% in the first quarter. Dimensional Fund Advisors LP now owns 3,962,514 shares of the company’s stock valued at $505,399,000 after buying an additional 21,953 shares during the last quarter. 91.73% of the stock is owned by institutional investors.
Shares of Aetna Inc. (NYSE:AET) opened at 152.15 on Friday. The firm has a 50-day moving average price of $154.26 and a 200 day moving average price of $139.02. The company has a market cap of $50.53 billion, a P/E ratio of 33.77 and a beta of 0.54. Aetna Inc. has a 12 month low of $104.59 and a 12 month high of $161.69.
Aetna (NYSE:AET) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.34 by $1.08. The business had revenue of $15.52 billion during the quarter, compared to analyst estimates of $15.34 billion. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The company’s revenue for the quarter was down 2.7% on a year-over-year basis. During the same period last year, the company earned $2.21 EPS. Equities analysts predict that Aetna Inc. will post $9.52 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Stockholders of record on Thursday, July 13th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.31%. The ex-dividend date of this dividend was Tuesday, July 11th. Aetna’s payout ratio is 43.67%.
TRADEMARK VIOLATION NOTICE: This piece of content was first reported by Daily Political and is the property of of Daily Political. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark law. The original version of this piece of content can be read at https://www.dailypolitical.com/2017/08/13/aetna-inc-nyseaet-stake-raised-by-umb-bank-n-a-mo.html.
AET has been the subject of several recent analyst reports. Stifel Nicolaus reissued a “buy” rating and set a $150.00 price objective (up previously from $130.00) on shares of Aetna in a report on Wednesday, May 3rd. Royal Bank Of Canada boosted their price objective on Aetna from $147.00 to $162.00 and gave the stock an “outperform” rating in a report on Friday, June 9th. BidaskClub lowered Aetna from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Deutsche Bank AG boosted their price objective on Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a report on Monday, August 7th. Finally, UBS AG reissued a “buy” rating and set a $160.00 price objective (up previously from $147.00) on shares of Aetna in a report on Wednesday, May 17th. Eight research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the stock. Aetna presently has a consensus rating of “Buy” and an average target price of $157.09.
In related news, EVP Margaret M. Mccarthy sold 27,028 shares of the firm’s stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the sale, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,008,606.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Chairman Mark T. Bertolini sold 103,547 shares of the firm’s stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $140.79, for a total value of $14,578,382.13. Following the sale, the chairman now directly owns 659,888 shares of the company’s stock, valued at $92,905,631.52. The disclosure for this sale can be found here. 0.90% of the stock is owned by company insiders.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.